Europe In Vitro Diagnostics (IVD) Market Overview:
Europe In Vitro Diagnostics (IVD) market was estimated at USD 19,679 million in 2018 and is expected to reach USD 25,459 million by 2025, which will grow at a compound annual growth rate of 3% over the 2018-2025 forecast period.
In vitro diagnostics are medical devices used to examine biological samples such as blood, urine, feces, tissues and other body fluids. The tests can be performed in an independent laboratory and in a hospital laboratory. Important technologies incorporated in IVD include polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry, which are used for the preparation of test samples.
Browse details of 150 number of pages research report developed on Europe In Vitro Diagnostics (IVD) Market Research Report @ https://www.researchcosmos.com/reports/europe-in-vitro-diagnostics-ivd-market/1284000888
Drivers, Challenges and Opportunities:
The increase in the prevalence of chronic diseases should stimulate this market growth. Increases in obesity, poor eating habits, sedentary lifestyle and high consumption of tobacco and alcohol are among the factors responsible for the high incidence of cancer, diabetes, cardiovascular disease and others disorders, supporting the IVD market. The growing geriatric population, which is prone to disease, needs regular diagnostic tests, which is one of the main factors of market growth. In addition, technological developments in terms of accuracy, portability and cost-effectiveness should accelerate the demand for IVD devices. Also, the growing demand for on-site processing devices is expected to stimulate market growth.
However, the shortage of experienced health professionals and the lack of awareness among the population limit market growth. There are also strict regulations on new and existing products and techniques that may limit market growth to a certain extent.
But the growing demand for portable in vitro diagnostic devices is one of the key factors driving business opportunities. It is hoped that the introduction of improved technologies such as miniaturization of microfluidics, biochips and Nano-biotechnology will increase opportunities in the future.
Ask Free Sample of the Report @ https://www.researchcosmos.com/request/europe-in-vitro-diagnostics-ivd-market/1284000888
Geographic Segmentation:
By country, the European IVD market it is analyzed in the regions of United Kingdom, Germany, France, Italy, Spain and the rest of Europe. France is expected to experience the highest growth rate over the forecast period. Increasing prevalence of chronic and infectious diseases and increasing public investment in R&D and medical care is driving market growth. France should become the region with maximum growth potential due to the concentration of key players in emerging economies and the improvement of health infrastructure.
Key market players:
BioMérieux SA, F. Hoffmann-La Roche Ltd. Becton, Dickinson and Company; Hologic, Inc. (Gen-Probe); Siemens Healthineers; Abbott; Alere Danaher; Sysmex Corporation; Qiagen; and Cepheid are some of the major players in this market.
For any queries, inquire more @ https://www.researchcosmos.com/inquire/europe-in-vitro-diagnostics-ivd-market/1284000888
About Us:
Research Cosmos is a provider of standard and customized Industry research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending Industry reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Media Contact
Company Name: Research Cosmos
Contact Person: Kevin Stewart
Email: Send Email
Phone: 1-888-709-8757
Address:4390 U.S 1, Suite 211
City: Princeton
State: New Jersey
Country: United States
Website: https://www.researchcosmos.com/reports/europe-in-vitro-diagnostics-ivd-market/1284000888